1-A/A LIVE 0001424812 XXXXXXXX 024-11084 Amarantus Bioscience Holdings, Inc. NV 2008 0001424812 2834 26-0690857 4 1 45 Wall Street Suite 920 New York NY 10005 650-862-5391 Eilers Law Group, P.A. Other 782666.00 4752840.00 0.00 0.00 5536762.00 14819860.00 20719825.00 35539685.00 -30002923.00 5536762.00 0.00 874090.00 50000.00 -824090.00 -0.01 -0.01 N/A 252504841 02300U205 OTCPinksheets Series A 250 000000000 N/A Series B 249999 000000000 N/A Series C 99 000000000 N/A Series D 0 000000000 N/A Series E 1140 000000000 N/A Series H 455 000000000 N/A N/A 0 000000000 N/A true true Tier1 Unaudited Equity (common or preferred stock) Y N Y Y N N 50000000 0.1000 5000000.00 0.00 0.00 0.00 5000000.00 Eilers Law Group, P.A. 15000.00 N/A 2000.00 4983000.00 true NY Amarantus Bioscience Holding, Inc. Series A Preferred 250 0 250 Amarantus Bioscience Holding, Inc. Series C Preferred 99 0 2) Exchange of 250,000 Series F Preferred ($25,000 value) and Cancellation of 25,530,667 common shares of Amarantus Amarantus Bioscience Holding, Inc. Convertible Debt 435349 0 435,349 cash Section 4(a)(2) and Section 3(a)(9) of the Securities Act